文献速递脑血管病

血液炎症标志物与卒中复发长期风险关联的持续存在:基于人群研究

Persistence of Association of Blood Biomarkers With Risk of Recurrent Stroke on Long-Term Follow-Up: Population-Based Study.
PubMed 文献 · Stroke · 2026-08-03

该研究基于OXVASC人群队列(2002-2011年,随访至2025年),纳入1292例TIA或卒中患者,评估12种血液标志物与复发卒中的关联。结果显示炎症标志物(IL-6、CRP、TNFR-1等)与10年复发风险独立相关,且关联强度随随访时间未见减弱,支持抗炎策略用于长期二级预防的试验。

要点

  • 炎症标志物(IL-6、CRP、TNFR-1)与TIA/卒中后10年复发风险独立相关。
  • 升高的炎症标志物数量越多,复发负担越高,且关联随时间延长未减弱。
  • 神经元损伤或血栓相关标志物对复发卒中的预测价值普遍较弱。

核心结论

  • 炎症标志物对长期复发卒中的预测价值高于神经元损伤或血栓标志物,尤其当多个炎症标志物升高时。

研究设计与样本

  • 基于人群的OXVASC研究(2002-2011年),随访至2025年,纳入1292例连续TIA或卒中患者,检测12种血液标志物。

主要发现

  • 平均随访11 336患者年期间,280例患者发生365次复发卒中。
  • 调整年龄、性别和基线血管危险因素后,IL-6的调整发病率比为1.21(95%CI 1.04-1.42),CRP为1.29(95%CI 1.11-1.49),TNFR-1为1.24(95%CI 1.05-1.46)。
  • 升高的炎症标志物数量与复发负担相关,发病率比为1.31(95%CI 1.15-1.50;P<0.001)。
  • 按时间分段的风险比:90天内为1.24(95%CI 0.98-1.57),90天至1年为1.24(95%CI 0.95-1.62),1至5年为1.22(95%CI 1.01-1.47),5至10年为1.34(95%CI 1.06-1.68)。
  • TIA和轻型卒中的关联相似,神经元损伤或血栓相关标志物的预测价值普遍较弱。

临床怎么用

  • 对TIA或卒中患者,可检测炎症标志物(如IL-6、CRP、TNFR-1)以辅助评估长期复发风险。
  • 多个炎症标志物同时升高提示复发负担更高,可能适合强化二级预防。
  • 研究结果支持开展抗炎策略用于长期二级预防的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Raised inflammatory biomarkers predict an increased short-term risk of recurrent vascular events after stroke or transient ischemic attack, but it is uncertain whether the hazard is maintained thereafter. In the absence of previous population-based studies, we aimed to determine the predictive value of biomarkers for the long-term risk of recurrent stroke in intensively treated patients following transient ischemic attack or stroke. METHODS: We studied 12 blood biomarkers related to inflammation, neuronal cell damage, and thrombosis soon after transient ischemic attack or stroke in a population-based study (OXVASC [Oxford Vascular Study]; 2002-2011) with follow-up to 2025. We used Cox and negative binomial regressions to assess associations between each log-transformed biomarker (per SD increase) and recurrent stroke (first event and total number), adjusted for age, sex, and baseline vascular risk factors. RESULTS: Of 1292 consecutive patients (mean/SD age, 73.1/13.2 years; 47.8% male), 365 recurrent strokes occurred in 280 patients during 11 336 patient-years. All inflammatory biomarkers were associated with 10-year risk of recurrence, with little impact of adjustment for other risk factors (adjusted incidence rate ratio: IL-6 [interleukin-6], 1.21 [95% CI, 1.04-1.42]; CRP [C-reactive protein], 1.29 [95% CI, 1.11-1.49]; TNFR-1 [tumor necrosis factor receptor-1], 1.24 [95% CI, 1.05-1.46]; and NGAL [neutrophil gelatinase-associated lipocalin], 1.15 [95% CI, 0.99-1.33]). Moreover, number of elevated (top quartile) inflammatory markers was associated with higher burden of recurrence (incidence rate ratio, 1.31 [95% CI, 1.15-1.50]; P<0.001), with no diminution over time (90 days: hazard ratio, 1.24 [95% CI, 0.98-1.57]; 90 days-1 year: 1.24 [95% CI, 0.95-1.62]; 1-5 years: 1.22 [95% CI, 1.01-1.47]; and 5-10 years: 1.34 [95% CI, 1.06-1.68]), and similar associations for transient ischemic attack and minor stroke. Biomarkers related to neuronal cell damage or thrombosis were generally less predictive of recurrent stroke. CONCLUSIONS: Inflammatory biomarkers were more predictive of long-term recurrent stroke than neuronal or thrombotic biomarkers, particularly when several inflammatory markers were raised. Predictive value was independent of other vascular risk factors and did not diminish with duration of follow-up, supporting trials of anti-inflammatory strategies for long-term secondary prevention.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Li L, Burgess AI, Duerden J, et al. Persistence of Association of Blood Biomarkers With Risk of Recurrent Stroke on Long-Term Follow-Up: Population-Based Study. Stroke. 2026. PMID: 42544483. doi:10.1161/STROKEAHA.126.056325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。